Annual Meeting Abstracts
The NOF ISO18 annual meeting has served as the premier event for scientific and clinical exchange in the field of osteoporosis and bone health. This year we will review abstract submission from the osteoporosis/bone health community from all over the world. A limited number of abstracts will be accepted for oral and poster presentations through an extensive peer review process. The Plenary Scientific Session, will include the top abstracts as selected by the Program Committee, and is one of the annual meeting program highlights.
2018 Call for Abstracts
ISO18 will be held Wednesday, May 16, through Saturday, May 19, 2018, in New Orleans, Louisiana. The goal of the NOF annual meeting is to present the best new scientific research in all areas of osteoporosis. All abstract submissions must be made electronically through NOF’s abstract submission portal. Abstract submission deadline is Friday, January 5, 2018, 11:59 p.m. (PDT).
Preferred Presentation Format
During submission, submitters must choose the formats in which they would be willing to present/publish their abstract. These choices must be made at the time of submission and cannot be changed after the review committee has reached its decision.
- Authors select whether they prefer oral or poster presentation. Abstracts noted with a preference for poster presentation will NOT be considered for oral presentation, regardless of score.
- In the event that an abstract is not chosen for oral presentation, it can still be chosen for poster presentation. Authors who state a preference for oral presentation must decide whether they would accept poster presentation. Authors may either present a poster or request that the abstract be immediately withdrawn. (Please note that declining to have your abstract considered for poster presentation does not improve its chances of being accepted as an oral presentation. This option should be selected primarily by authors who would not be willing to present a poster.)
Please be sure your abstract contains the following prior to submission:
- A sentence stating the study’s objective (unless this is provided in the title)
- A brief statement of methods, if pertinent
- A summary of the results obtained
- A statement of conclusion (it is not acceptable to state, “the results will be discussed”)
Please follow these guidelines when formatting your abstract:
- Use a short, specific title. The title should be entered in sentence-style capitalization (i.e. Modeling cytoskeletal structures with Cytosim). Please do not use a period, or place your title in quotes, use bold, or use ALL CAPS.
- Capitalize initial letters of trade names.
- Please do not write given or family names, titles, or abstracts in ALL CAPS.
- Use standard abbreviations for units of measure; other abbreviations should be spelled out in full at first mention, followed by the abbreviation in parenthesis (exceptions: RNA, DNA, etc.).
- Please do not include tables, charts, or other figures.
- Be sure to proofread your work carefully before submission. Please ensure your abstract and submission details are correct. It will be printed exactly as it appears in the abstract submission system.
Special Characters and Formatting:
Character Limit/Word Count
- The abstract text is limited to 2,800 characters, including spaces (~400 words). This limit includes the body of the abstract only. If your abstract exceeds this limit, you will be prompted to shorten it before being allowed to continue.
- The abstract title is limited to 200 characters, including spaces.
- There is no character limit for your authors or author affiliations.
Abstract Review and Selection Process
After the submission deadline, all completed and eligible abstracts will be made available to the NOF Abstract Reviewers for blinded review and scoring, and final decisions will be made by the Program Committee in late January 2018.
Abstracts will be evaluated and scored solely on their scientific merits. Incomplete abstracts will not be reviewed. The same study must not be submitted as multiple abstracts. Abstracts that are simply different versions of a single study will be rejected. Abstracts will be peer reviewed according to the subject categories. Authors must indicate during online submission the appropriate review category (one only). Please use the list of abstract review categories. Read through all of the categories and select the category most closely associated with your abstract. All category selections will be final. There will be NO re-classification of abstracts after the abstract submission site has been closed. Abstracts submitted to the wrong category are scored in that category and usually fare poorly.
All abstracts submitted will be considered eligible for one presentation: either plenary, oral (simultaneous session), or poster.
The Plenary Session features the top abstracts. These are formal oral presentations, each followed by a brief discussion. An NOF member selected by the Program Committee will give a brief introduction to the abstract.
Oral (simultaneous) Sessions are formal oral presentations followed by a brief discussion.
Poster Sessions allow the viewing of a poster illustration of the abstract. Authors are expected to post and remove posters at designated times and to be at their posters to answer questions during the time designated for poster presentations. The author’s attendance during poster presentation time will be monitored.
Notification regarding acceptance or rejection of abstracts will be sent to the presenting author in January 2018 by email; consequently, an accurate email address is critical. If your abstract is accepted, the email will specify whether it is accepted as plenary, oral, or poster presentation or whether it has been selected to be published online only. If you have not received an email notification by February 2, 2018, contact Catrell Harris at email@example.com. Rejection notifications will also be sent at that time.
The decision of the NOF Program Committee regarding acceptance and presentation of abstracts is final.